IN8bio Inc: A Year of Highs, Lows, and Market Resilience

IN8bio Inc (INAB) has a current stock price of $0.87. During the previous trading session, the stock witnessed a notable rise, reaching a high of $0.92 after opening at $0.91. The stock’s low for the day was $0.851, and it eventually closed at $0.91.

The market performance of IN8bio Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $3.95 on 04/24/23, with the lowest value for the same timeframe being $0.88, recorded on 11/20/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of INAB Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. IN8bio Inc’s current trading price is -78.10% away from its 52-week high, while its distance from the 52-week low is -1.44%. The stock’s price range during this period has fluctuated between $0.88 and $3.95. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.15 million for the day, which was evidently higher than the average daily volume of 81730.0 over the last three months.

Financial Performance and Market Capitalization

IN8bio Inc (INAB) has experienced a quarterly decline of -23.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 27.67M and boasts a workforce of 26 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1543, with a change in price of -0.7550. Similarly, IN8bio Inc recorded 119,488 in trading volume during the last 100 days, posting a change of -46.60%.

INAB Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for INAB stands at 0.30. Similarly, the long-term debt-to-equity ratio is also 0.21.

INAB Stock Stochastic Average

IN8bio Inc’s raw stochastic average for the past 50 days is currently at 3.34%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 5.02%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 11.67% and 18.34%, respectively.

INAB Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -62.55% this year. Over the last six months, there has been a stronger performance of -68.20%. The price of INAB leaped by -12.26% during the last 30 days period. For the last 5-days stocks have slided -17.62%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts